Cited by 2,070T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersHIV Research and Treatment

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Open access

Im, Se Jin, Hashimoto, Masao, Gerner, Michael Y., Lee, Junghwa, Kissick, Haydn T., Burger, Matheus C., Shan, Qiang, Hale, J. Scott, Lee, Judong, Nasti, Tahseen H., Sharpe, Arlene H., Freeman, Gordon J., Germain, Ronald N., Nakaya, Helder I., Xue, Hai-Hui, Ahmed, Rafi·2016·Nature

DOI 10.1038/nature19330PMC PMC5297183

Open this paper in CoChat — free account

Abstract

Chronic viral infections are characterized by a state of CD8+ T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor. A better understanding of the mechanisms that regulate CD8+ T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8+ T cells. Here we identify a population of virus-specific CD8+ T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8+ T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8+ T-cell subset was characterized by a unique gene signature that was related to that of CD4+ T follicular helper (T FH) cells, CD8+ T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4+ T H 1 cells and CD8+ terminal effectors. This CD8+ T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8+ T cells. These PD-1+CD8+ T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8+ T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8+ T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8+ T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature19330

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toll-Like Receptors
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citation
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Self-citation
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citation
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Self-citation
Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,677
Self-citation

Show all 37 references

Sorted by citations

Items 701–800 of 1,003

T‐cell memory in tissues
van Gisbergen, K. P. J. M., Zens, K. D., & Münz, C. (2021) · European Journal of Immunology · doi:10.1002/eji.202049062 · Cited by 39
Epigenetic regulation of T cell adaptive immunity
Frias, A. B., Boi, S. K., Lan, X., & Youngblood, B. (2021) · Immunological Reviews · doi:10.1111/imr.12943 · Cited by 44
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Broomfield, B. J., Tan, C. W., Qin, R. Z., Abberger, H., Duckworth, B. C., Alvarado, C., Dalit, L., Lee, C. L., Mugan, R. S., Mazrad, Z. A. I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241148 · Cited by 42
Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
Okoye, I., Namdar, A., Xu, L., Crux, N. B., & Elahi, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21003 · Cited by 41
Immunological cure of HBV infection
Lang‐Meli, J., Neumann‐Haefelin, C., & Thimme, R. (2019) · Hepatology International · doi:10.1007/s12072-018-9912-8 · Cited by 41
A Thpok-Directed Transcriptional Circuitry Promotes Bcl6 and Maf Expression to Orchestrate T Follicular Helper Differentiation
Vacchio, M. S., Ciucci, T., Gao, Y., Watanabe, M., Balmaceno-Criss, M., McGinty, M. T., Huang, A., Xiao, Q., McConkey, C., Zhao, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.023 · Cited by 42
Common gamma chain cytokines and CD8 T cells in cancer
Shourian, M., Beltra, J., Bourdin, B., & Decaluwe, H. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101307 · Cited by 43
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
Bardhan, K., Aksoylar, H., Bourgeois, T. L., Strauss, L., Weaver, J. D., Delcuze, B., Charest, A., Patsoukis, N., & Boussiotis, V. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53463-0 · Cited by 41
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells
Martínez-Usatorre, A., Carmona, S. J., Godfroid, C., Maroun, C. Y., Labiano, S., & Romero, P. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00340 · Cited by 41
The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review
Zaborowski, A. M., Winter, D. C., & Lynch, L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01475-x · Cited by 40
Dynamic CD4+ T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection
Snell, L. M., Xu, W., Abd-Rabbo, D., Boukhaled, G. M., Guo, M., MacLeod, B., Elsaesser, H. J., Hezaveh, K., Alsahafi, N., Lukhele, S., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01060-7 · Cited by 40
Epigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Perdomo-Celis, F., Passaes, C., Monceaux, V., Volant, S., Boufassa, F., de Truchis, P., Marcou, M., Bourdic, K., Weiss, L., Jung, C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157549 · Cited by 44
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment
Tundo, G. R., Sbardella, D., Lacal, P. M., Graziani, G., & Marini, S. (2019) · Chemotherapy · doi:10.1159/000500902 · Cited by 41
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
Gangaev, A., Rozeman, E. A., Rohaan, M. W., Isaeva, O. I., Philips, D., Patiwael, S., van den Berg, J. H., Ribas, A., Schadendorf, D., Schilling, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102849118 · Cited by 41
Metabolic dynamics instruct CD8 + T‐cell differentiation and functions
Bevilacqua, A., Li, Z., & Ho, P. (2022) · European Journal of Immunology · doi:10.1002/eji.202149486 · Cited by 41
A variety of ‘exhausted’ T cells in the tumor microenvironment
Nagasaki, J., & Togashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac013 · Cited by 43
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Ding, J., Yang, K., Zhou, H., Huang, Y.-F., Li, H., & Zong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149622 · Cited by 45
Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Ruggiu, M., Guérin, M. V., Corre, B., Bardou, M., Alonso, R., Russo, E., Garcia, Z., Feldmann, L., Lemaı̂tre, F., Dusséaux, M., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232104 · Cited by 42
Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
Mylvaganam, G., Yanez, A. G., Maus, M. V., & Walker, B. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02109 · Cited by 38
Integrating resident memory into T cell differentiation models
Rosato, P. C., Wijeyesinghe, S., Stolley, J. M., & Masopust, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.001 · Cited by 40
Diverse Roles of Akt in T cells
Abdullah, L., Hills, L. B., Winter, E. B., & Huang, Y. H. (2021) · Immunometabolism · doi:10.20900/immunometab20210007 · Cited by 42
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
Relecom, A., Merhi, M., Inchakalody, V. P., Shahab Uddin, M. S., Rinchai, D., Bedognetti, D., & Dermime, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01872-3 · Cited by 41
New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy
Greene, E., Finak, G., D’Amico, L., Bhardwaj, N., Church, C. D., Morishima, C., Ramchurren, N., Taube, J. M., Nghiem, P., Cheever, M. A., et al. (2021) · Patterns · doi:10.1016/j.patter.2021.100372 · Cited by 40
TGF-β-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine
Li, G., Srinivasan, S., Wang, L., Ma, C., Guo, K., Xiao, W., Liao, W., Mishra, S., Zhang, X., Qiu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33768-x · Cited by 40
Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans
Li, Y., Ramírez-Suástegui, C., Harris, R. J., Castañeda-Castro, F. E., Ascui, G., Pérez-Jeldres, T., Diaz, A., Morong, C., Giles, D. A., Chai, J. N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01860-7 · Cited by 39
Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy
Wu, Y., Liu, B., Yan, Y., Gong, C., Wang, K., Liu, N., Zhu, Y., Li, M., Wang, C., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54883-x · Cited by 48
Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis
Inamo, J., Keegan, J., Griffith, A. M., Ghosh, T., Horisberger, A., Howard, K., Pulford, J. F., Murzin, E., Hancock, B. L., Dominguez, S. T., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185217 · Cited by 48
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
Bachem, A., Clarke, M. V., Kong, G., Tarasova, I., Dryburgh, L., Kosack, L., Lee, A. R., Newland, L. G. M., Wagner, T., Bawden, E., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.004 · Cited by 46
Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy
Gu, K., Liang, T., Hu, L., Zhao, Y., Ying, W., Zhang, M., Chen, Y., Liang, B., Lin, X., Zhang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67674-9 · Cited by 54
Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice
Jing, W., Gershan, J. A., Blitzer, G. C., Palen, K. A., Weber, J. J., McOlash, L., Riese, M. J., & Johnson, B. D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0256-z · Cited by 39
Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation
Shin, B., Kress, R. L., Kramer, P. A., Darley-Usmar, V. M., Bellis, S. L., & Harrington, L. E. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172335 · Cited by 39
Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy
Liu, C., Wang, J., An, N., Li, A., Yan, W., Zhu, H., & Yu, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2097-7 · Cited by 41
TCF-1 maintains CD8+ T cell stemness in tumor microenvironment
Wen, S., Lu, H., Wang, D., Guo, J., Dai, W., & Wang, Z. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr1120-778r · Cited by 43
Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients
Guo, A.-L., Jiao, Y., Zhao, Q., Huang, H.-H., Deng, J., Zhang, C., Fan, X., Xu, R., Zhang, J., Zhen, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103794 · Cited by 39
Advancing beyond the twists and turns of T cell exhaustion in cancer
van der Heide, V., Humblin, É., Vaidya, A. B., & Kamphorst, A. O. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4997 · Cited by 41
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
Fransen, M. F., van Hall, T., & OSSENDORP, F. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179401 · Cited by 39
Krüppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells
Nah, J., & Seong, R. H. (2022) · Science Advances · doi:10.1126/sciadv.adc9346 · Cited by 40
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT
Senjo, H., Harada, S., Kubota, S. I., Tanaka, Y., Tateno, T., Zhang, Z., Okada, S., Chen, X., Kikuchi, R., Miyashita, N., et al. (2023) · Blood · doi:10.1182/blood.2023019875 · Cited by 41
Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression
Long, S., Huang, G., Ouyang, M., Xiao, K., Zhou, H., Hou, A., Li, Z., Zhong, Z., Zhong, D., Wang, Q., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05878-x · Cited by 38
Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex
Li, Y., Han, M., Wei, H., Huang, W., Chen, Z., Zhang, T., Qian, M., Lin, J., Nan, G., Sun, X., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01118-6 · Cited by 39
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates
Becker, J. C., Stang, A., Schrama, D., & Ugurel, S. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00858-z · Cited by 42
EGFR mutations induce the suppression of CD8+ T cell and anti-PD-1 resistance via ERK1/2-p90RSK-TGF-β axis in non-small cell lung cancer
Huang, H., Zhu, X., Yu, Y., Li, Z., Yang, Y., Xia, L., & Lü, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05456-5 · Cited by 38
CD4 T cell dysfunction is associated with bacterial recrudescence during chronic tuberculosis
Chang, E., Cavallo, K., & Behar, S. M. (2025) · Nature Communications · doi:10.1038/s41467-025-57819-1 · Cited by 39
Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function
Cannons, J. L., Preite, S., Kapnick, S. M., Uzel, G., & Schwartzberg, P. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01758 · Cited by 37
Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
Yasuoka, H., Asai, A., Ohama, H., Tsuchimoto, Y., Fukunishi, S., & Higuchi, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-67497-2 · Cited by 38
Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection
Milner, J. J., Toma, C., Quon, S., Omilusik, K. D., Scharping, N. E., Dey, A., Reina‐Campos, M., Nguyen, H., Getzler, A. J., Diao, H., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202512 · Cited by 38
Spatial determinants of CD8+ T cell differentiation in cancer
Tooley, K., Escobar, G., & Anderson, A. C. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.04.003 · Cited by 38
CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy
Ando, S., & Araki, K. (2022) · International Immunology · doi:10.1093/intimm/dxac038 · Cited by 36
TET2 regulates early and late transitions in exhausted CD8 + T cell differentiation and limits CAR T cell function
Dimitri, A. J., Baxter, A. E., Chen, G. M., Hopkins, C. R., Rouin, G. T., Huang, H., Kong, W., Holliday, C., Wiebking, V., Bartoszek, R. L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp9371 · Cited by 42
Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response
Voss, K., Larsen, S. E., & Snow, A. L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.033 · Cited by 38
T-cell phenotypes are associated with serum IgE levels in Amish and Hutterite children
Hrusch, C. L., Stein, M. M., Gozdz, J., Holbreich, M., von Mutius, E., Vercelli, D., Ober, C., & Sperling, A. I. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.034 · Cited by 37
Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation.
Cao, W.-Q., Fang, F., Gould, T. M., Li, X., Kim, C., Gustafson, C., Lambert, S., Weyand, C., & Goronzy, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132417 · Cited by 34
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer
Pack, C. D., Bommireddy, R., Muñoz, L. E., Patel, J. M., Bozeman, E. N., Dey, P., Radhakrishnan, V., Vartabedian, V. F., Venkat, K., Ramachandiran, S., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1754691 · Cited by 37
Interrogating Adaptive Immunity Using LCMV
Dangi, T., Chung, Y. R., Palacio, N. M., & Penaloza‐MacMaster, P. (2020) · Current Protocols in Immunology · doi:10.1002/cpim.99 · Cited by 34
Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
Topchyan, P., Xin, G., Chen, Y., Zheng, S., Burns, R., Shen, J., Kasmani, M. Y., Kudek, M. R., Yang, N., & Cui, W. (2021) · Cancers · doi:10.3390/cancers13061263 · Cited by 39
Recent advances in microfluidics for single-cell functional proteomics
Gebreyesus, S. T., Muneer, G., Huang, C., Siyal, A. A., Anand, M., Chen, Y., & Tu, H. (2023) · Lab on a Chip · doi:10.1039/d2lc01096h · Cited by 35
Arf1 Ablation in Colorectal Cancer Cells Activates a Super Signal Complex in DC to Enhance Anti‐Tumor Immunity
Ma, H., Fang, W., Li, Q., Wang, Y., & Hou, X. S. (2023) · Advanced Science · doi:10.1002/advs.202305089 · Cited by 35
Mitochondrial Metabolism in T-Cell Exhaustion
Li, F., Yu, F., Yin, Z., & Wang, Y. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157400 · Cited by 42
Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection
Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01241 · Cited by 38
Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation
Price, M. J., Scharer, C. D., Kania, A. K., Randall, T. D., & Boss, J. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000551 · Cited by 35
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
Egelston, C. A., Guo, W., Yost, S. E., Lee, J. S., Rose, D. L., Avalos, C., Ye, J., Frankel, P. H., Schmolze, D. D., Waisman, J. R., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002084 · Cited by 36
Self-citation
The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer
Beumer‐Chuwonpad, A., Taggenbrock, R. L. R. E., Ngo, T. A., & van Gisbergen, K. P. J. M. (2021) · Cells · doi:10.3390/cells10092234 · Cited by 40
The role of neoantigens in tumor immunotherapy
Shang, S., Zhao, Y., Qian, K., Qin, Y., Zhang, X., Li, T., Shan, L., Wei, M., Xi, J., & Tang, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113118 · Cited by 37
Functional differences between rodent and human PD-1 linked to evolutionary divergence
Masubuchi, T., Chen, L., Marcel, N., Wen, G. A., Caron, C., Zhang, J., Zhao, Y., Morris, G. P., Chen, X., Hedrick, S. M., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads6295 · Cited by 36
Mechanisms of immunogenic cell death and immune checkpoint blockade therapy
Lin, R. A., Lin, J. K., & Lin, S. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12375 · Cited by 38
Virtual memory T cells orchestrate extralymphoid responses conducive to resident memory
Hou, S., Shao, T., Mao, T., Shi, J., Sun, J., Mei, M., Tan, X., & Qi, H. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg9433 · Cited by 36
The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
Zhang, J., Lei, F., & Tan, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166128 · Cited by 39
Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity
Khanal, S., Wieland, A., & Gunderson, A. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267654 · Cited by 35
ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion
Cheng, J., Xiao, Y., Peng, T., Zhang, Z., Qin, Y., Wang, Y., Shi, J., Yan, J., Zhao, Z., He, Z., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00892-0 · Cited by 37
Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer
Liu, C., Hu, Q., Hu, K., Su, H., Shi, F., Kong, L., Zhu, H., & Yu, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1872-9 · Cited by 38
Striking a Balance—Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation
Hope, J. L., Stairiker, C. J., Bae, E., Otero, D. C., & Bradley, L. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01595 · Cited by 38
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
Asleh, K., Brauer, H. A., Sullivan, A. H., Lauttia, S., Lindman, H., Nielsen, T. O., Joensuu, H., Thompson, E. A., & Chumsri, S. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1945 · Cited by 35
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development
Katkeviciutė, E., Hering, L., Montalban‐Arques, A., Busenhart, P., Schwarzfischer, M., Manzini, R., Conde, J., Atrott, K., Lang, S., Rogler, G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140281 · Cited by 34
The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude
Li, Z.-Y., Morman, R. E., Hegermiller, E., Sun, M., Bartom, E. T., Maienschein‐Cline, M., Sigvardsson, M., & Kee, B. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202032 · Cited by 37
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells
Chen, C.-Y., Ueha, S., Ishiwata, Y., Shichino, S., Yokochi, S., Yang, D., Oppenheim, J. J., Ogiwara, H., Deshimaru, S., Kanno, Y., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0265 · Cited by 34
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
Verdon, D. J., & Jenkins, M. R. (2021) · Cancers · doi:10.3390/cancers13164245 · Cited by 36
The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy
Wong, W., Yin, B., Lam, C. Y. K., Huang, Y., Yan, J., Tan, Z., & Wong, S. H. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783227 · Cited by 35
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
Turinetto, M., Valsecchi, A. A., Tuninetti, V., Scotto, G., Borella, F., & Valabrega, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073559 · Cited by 35
Facts and Hopes for Immunotherapy in Renal Cell Carcinoma
Yao, C., Zhang, T., Wu, T., & Brugarolas, J. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2372 · Cited by 35
Learning from the nexus of autoimmunity and cancer
Mangani, D., Yang, D., & Anderson, A. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.022 · Cited by 33
Opposing effects of T cell receptor signal strength on CD4 T cells responding to acute versus chronic viral infection
Künzli, M., Reuther, P., Pinschewer, D. D., & King, C. G. (2021) · eLife · doi:10.7554/elife.61869 · Cited by 35
Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Pich-Bavastro, C., Yerly, L., Domizio, J. D., Tissot-Renaud, S., Gilliet, M. F., & Kuonen, F. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0219 · Cited by 35
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Xiong, D., Zhang, L., & Sun, Z. (2023) · Military Medical Research · doi:10.1186/s40779-023-00496-2 · Cited by 36
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Shah, V., Panchal, V. S., Shah, A., Vyas, B., Agrawal, S. P., & Bharadwaj, S. P. (2024) · Medicine International · doi:10.3892/mi.2024.137 · Cited by 37
Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state
Mangani, D., Subramanian, A., Huang, L., Cheng, H., Krovi, S. H., Wu, Y., Yang, D., Moreira, T. G., Escobar, G., Schnell, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.017 · Cited by 35
Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics
Jackson, S. R., Flemming, J. P., Karagoz, K., Wermuth, P. J., & Mahoney, M. G. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.70017 · Cited by 42
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
Gálvez‐Cancino, F., Navarrete, M., Beattie, G., Puccio, S., Conde, E., Foster, K. A., Morris, Y., Sahwangarrom, T., Karagianni, D., Liu, J., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.021 · Cited by 37
Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
Pagé, N., Lemeille, S., Vincenti, I., Klimek, B., Mariotte, A., Wagner, I., Liberto, G. D., Kaye, J., & Merkler, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21109-3 · Cited by 36
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
Li, X., Yang, Y., Huang, Q., Deng, Y., Guo, F., Wang, G., & Liu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.738373 · Cited by 36
The multifaceted functions of cGAS
Liu, H., Wang, F., Cao, Y., Dang, Y., & Ge, B. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac031 · Cited by 38
Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma
Cheng, D., Qiu, K., Rao, Y., Mao, M., Li, L., Wang, Y., Song, Y., Chen, J., Yi, X., Shao, X., et al. (2023) · eLife · doi:10.7554/elife.82705 · Cited by 35
Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
Lee, J., & Kim, E. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1233376 · Cited by 36
Self-citation
Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis
Ma, X., Wang, Q., Sun, C., Agarwal, I., Wu, H., Chen, J., Zhao, C., Qi, G., Teng, Q., Yuan, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112944 · Cited by 34
NR4A1 transcriptionally regulates the differentiation of stem-like CD8+ T cells in the tumor microenvironment
Hao, J., Li, R., Zhao, X., Liu, X., Chen, X., Xie, T., Li, X., Yao, C., Sun, Q., Wei, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114301 · Cited by 35
Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence
Strongin, Z., Marchand, L. R., Deléage, C., Pampena, M. B., Cardenas, M. A., Beusch, C. M., Hoang, T. N., Urban, E., Gourvès, M., Nguyen, K., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01875-0 · Cited by 37
Self-citation
The role of RICTOR amplification in targeted therapy and drug resistance
Zhao, D., Jiang, M., Zhang, X., & Hou, H. (2020) · Molecular Medicine · doi:10.1186/s10020-020-0146-6 · Cited by 35
The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
Chen, H., Moussa, M., & Catálfamo, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01223 · Cited by 33
Reversal of T Cell Exhaustion in Chronic HCV Infection
Osuch, S., Metzner, K. J., & Cortés, K. C. (2020) · Viruses · doi:10.3390/v12080799 · Cited by 34

Authors: Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., Sharpe, A. H., Freeman, G. J., Germain, R. N., Nakaya, H. I., Xue, H.-H., & Ahmed, R.
Affiliations: Emory University (US)
National Institutes of Health (US)
University of Iowa (US)
Brigham and Women's Hospital (US)
Harvard University (US)
Universidade de São Paulo (BR)
Corresponding author: Ahmed, Rafi
ORCID: Im, Se Jin
Hashimoto, Masao
Gerner, Michael Y.
Lee, Junghwa
Kissick, Haydn T.
Shan, Qiang
Hale, J. Scott
Lee, Judong
Nasti, Tahseen H.
Sharpe, Arlene H.
Freeman, Gordon J.
Germain, Ronald N.
Nakaya, Helder I.
Xue, Hai-Hui
Ahmed, Rafi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2016-08-02
Volume: 537
Issue: 7620
Pages: 417-421
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature19330
PMC: PMC5297183
OpenAlex: W2506616866
Cited by: 2,070
References: 37
Citations by year: 2026: 224 · 2025: 245 · 2024: 268 · 2023: 264 · 2022: 248 · 2021: 252 · 2020: 223 · 2019: 154 · 2018: 101 · 2017: 75 · 2016: 13
FWCI: 69.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health (n01ai30048-10-0-1)
National Institute of Allergy and Infectious Diseases (N01 AI030048, P01AI080192, P01AI056299, R01AI030048, R01AI121080, R01AI112579)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: CD8+ T cells, PD-1, T cell exhaustion, lymphocytic choriomeningitis virus, chronic viral infection, B cell follicles, T follicular helper cells, PD-L1 blockade, anti-PD-1 therapy, HIV, virus control, costimulatory molecules
MeSH terms: Cell Self Renewal, Animals, Cell Differentiation, Female, T-Lymphocytes, Helper-Inducer, Hematopoietic Stem Cells, Immunotherapy, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, T-Lymphocyte Subsets, CD28 Antigens, CD8-Positive T-Lymphocytes, Cell Proliferation, Mice, Hepatocyte Nuclear Factor 1-alpha, Inducible T-Cell Co-Stimulator Protein, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks